Deep Track Capital, LP 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 09:01 am Purchase |
2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Deep Track Capital, LP | 5,378,997 9.900% |
2,066,023 (+62.36%) |
Filing |
| 2023-02-14 08:59 am Purchase |
2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Deep Track Capital, LP | 3,312,974 7.930% |
1,493,285 (+82.06%) |
Filing |
| 2021-09-24 5:01 pm Purchase |
2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN |
Deep Track Capital, LP | 1,819,689 9.900% |
1,819,689 (New Position) |
Filing |